Avalo Therapeutics, Inc. · NASDAQ:AVTX
Riley Jennifer sold 2,655 Avalo Therapeutics, Inc. shares (Form 4)
Traded Aug 11, 2026 · Filed Aug 12, 2026
On Aug 11, 2026, Riley Jennifer (Chief Strategy Officer) sold 2,655 Avalo Therapeutics, Inc. shares at US$19.59 for US$52,011, leaving 37,041 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 2,655 shares
- Price
- US$19.59
- Value
- US$52,011
- Holding after
- 37,041 shares
- Trading plan
- No
- Role
- Chief Strategy Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 11, 2026 | Common Stock | Sale | 2,655 | US$19.59 | 37,041 | Direct |
Source
Related
- Avalo Therapeutics, Inc.
- Riley Jennifer
- Avalo Therapeutics, Inc. shareholders
- Form 4 · Riley Jennifer · Jun 12, 2026
- Form 4 · Riley Jennifer · May 26, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 18, 2026
- Form 4 · Sullivan Christopher Ryan · Sep 11, 2026
- Form 4 · Doyle Mittie · Sep 1, 2026
- Form 4 · Sullivan Christopher Ryan · Aug 19, 2026
- Form 4 · Doyle Mittie · Aug 19, 2026